RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Richard Yanagihara to Cell Line

This is a "connection" page, showing publications Richard Yanagihara has written about Cell Line.
Connection Strength

0.743
  1. Lu Y, Aguirre AA, Wang Y, Zeng L, Loh PC, Yanagihara R. Viral susceptibility of newly established cell lines from the Hawaiian monk seal Monachus schauinslandi. Dis Aquat Organ. 2003 Dec 29; 57(3):183-91.
    View in: PubMed
    Score: 0.185
  2. Lu Y, Aguirre AA, Hamm C, Wang Y, Yu Q, Loh PC, Yanagihara R. Establishment, cryopreservation, and growth of 11 cell lines prepared from a juvenile Hawaiian monk seal, Monachus schauinslandi. Methods Cell Sci. 2000; 22(2-3):115-24.
    View in: PubMed
    Score: 0.140
  3. Lu Y, Nerurkar VR, Aguirre AA, Work TM, Balazs GH, Yanagihara R. Establishment and characterization of 13 cell lines from a green turtle (Chelonia mydas) with fibropapillomas. In Vitro Cell Dev Biol Anim. 1999 Jul-Aug; 35(7):389-93.
    View in: PubMed
    Score: 0.135
  4. Lu Y, Aguirre AA, Work TM, Balazs GH, Nerurkar VR, Yanagihara R. Identification of a small, naked virus in tumor-like aggregates in cell lines derived from a green turtle, Chelonia mydas, with fibropapillomas. J Virol Methods. 2000 Apr; 86(1):25-33.
    View in: PubMed
    Score: 0.036
  5. Yanagihara R, Saitou N, Nerurkar VR, Song KJ, Bastian I, Franchini G, Gajdusek DC. Molecular phylogeny and dissemination of human T-cell lymphotropic virus type I viewed within the context of primate evolution and human migration. Cell Mol Biol (Noisy-le-grand). 1995; 41 Suppl 1:S145-61.
    View in: PubMed
    Score: 0.025
  6. Nerurkar VR, Song KJ, Melland RR, Yanagihara R. Genetic and phylogenetic analyses of human T-cell lymphotropic virus type I variants from Melanesians with and without spastic myelopathy. Mol Neurobiol. 1994 Apr-Jun; 8(2-3):155-73.
    View in: PubMed
    Score: 0.024
  7. Kaufusi PH, Kelley JF, Yanagihara R, Nerurkar VR. Induction of endoplasmic reticulum-derived replication-competent membrane structures by West Nile virus non-structural protein 4B. PLoS One. 2014; 9(1):e84040.
    View in: PubMed
    Score: 0.023
  8. Hoshino H, Nakamura T, Tanaka Y, Miyoshi I, Yanagihara R. Functional conservation of the neutralizing domains on the external envelope glycoprotein of cosmopolitan and melanesian strains of human T cell leukemia/lymphoma virus type I. J Infect Dis. 1993 Dec; 168(6):1368-73.
    View in: PubMed
    Score: 0.023
  9. Shin OS, Kumar M, Yanagihara R, Song JW. Hantaviruses induce cell type- and viral species-specific host microRNA expression signatures. Virology. 2013 Nov; 446(1-2):217-24.
    View in: PubMed
    Score: 0.023
  10. Yanagihara R, Nerukar VR, Ajdukiewicz AB. Comparison between strains of human T lymphotropic virus type I isolated from inhabitants of the Solomon Islands and Papua New Guinea. J Infect Dis. 1991 Sep; 164(3):443-9.
    View in: PubMed
    Score: 0.020
  11. Yanagihara R, Ajdukiewicz AB, Nerurkar VR, Garruto RM, Gajdusek DC. Verification of HTLV-I infection in the Solomon Islands by virus isolation and gene amplification. Jpn J Cancer Res. 1991 Mar; 82(3):240-4.
    View in: PubMed
    Score: 0.019
  12. Wu C, Nerurkar VR, Yanagihara R, Lu Y. Effective modifications for improved homologous recombination and high-efficiency generation of recombinant adenovirus-based vectors. J Virol Methods. 2008 Nov; 153(2):120-8.
    View in: PubMed
    Score: 0.016
  13. Okumura M, Yoshimatsu K, Kumperasart S, Nakamura I, Ogino M, Taruishi M, Sungdee A, Pattamadilok S, Ibrahim IN, Erlina S, Agui T, Yanagihara R, Arikawa J. Development of serological assays for Thottapalayam virus, an insectivore-borne Hantavirus. Clin Vaccine Immunol. 2007 Feb; 14(2):173-81.
    View in: PubMed
    Score: 0.014
  14. Verma S, Ziegler K, Ananthula P, Co JK, Frisque RJ, Yanagihara R, Nerurkar VR. JC virus induces altered patterns of cellular gene expression: interferon-inducible genes as major transcriptional targets. Virology. 2006 Feb 20; 345(2):457-67.
    View in: PubMed
    Score: 0.013
  15. Yanagihara R, Goldgaber D, Lee PW, Amyx HL, Gajdusek DC, Gibbs CJ, Svedmyr A. Propagation of nephropathia epidemica virus in cell culture. Lancet. 1984 May 05; 1(8384):1013.
    View in: PubMed
    Score: 0.012
  16. Yanagihara RT, Asher DM, Gibbs CJ, Gajdusek DC. Attempts to establish cell cultures infected with the viruses of subacute spongiform encephalopathies. Proc Soc Exp Biol Med. 1980 Nov; 165(2):298-305.
    View in: PubMed
    Score: 0.009
  17. Lazo A, Bailer RT, Blakeslee JR, Yanagihara R, Stevens VC, Kramer L, Lairmore MD. Immune recognition of genetically diverse simian T-cell lymphotropic virus type I isolates. Arch Virol. 1995; 140(2):307-23.
    View in: PubMed
    Score: 0.006
  18. Rajc?ni J, Yanagihara R, Godec MS, Nagle JW, Kudelova M, Asher DM. Low-incidence latent infection with variant B or roseola type human herpesvirus 6 in leukocytes of healthy adults. Arch Virol. 1994; 134(3-4):357-68.
    View in: PubMed
    Score: 0.006
  19. Benson J, Tschachler E, Gessain A, Yanagihara R, Gallo RC, Franchini G. Cross-neutralizing antibodies against cosmopolitan and Melanesian strains of human T cell leukemia/lymphotropic virus type I in sera from inhabitants of Africa and the Solomon Islands. AIDS Res Hum Retroviruses. 1994 Jan; 10(1):91-6.
    View in: PubMed
    Score: 0.006
  20. Nerurkar VR, Wakayama I, Rowe T, Yanagihara R, Garruto RM. Preliminary observations on the in vitro toxicity of N-butylbenzenesulfonamide: a newly discovered neurotoxin. Ann N Y Acad Sci. 1993 May 28; 679:280-7.
    View in: PubMed
    Score: 0.006
  21. Nara PL, Robey WG, Arthur LO, Gonda MA, Asher DM, Yanagihara R, Gibbs CJ, Gajdusek DC, Fischinger PJ. Simultaneous isolation of simian foamy virus and HTLV-III/LAV from chimpanzee lymphocytes following HTLV-III or LAV inoculation. Arch Virol. 1987; 92(1-2):183-6.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support